These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33820504)

  • 1. Multitarget Directed Ligand Approaches for Alzheimer's Disease: A Comprehensive Review.
    Ramalakshmi N; R S R; C N N
    Mini Rev Med Chem; 2021; 21(16):2361-2388. PubMed ID: 33820504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer's Disease.
    Yamali C; Donmez S
    Mini Rev Med Chem; 2023; 23(7):869-880. PubMed ID: 36464869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease.
    Mesiti F; Chavarria D; Gaspar A; Alcaro S; Borges F
    Eur J Med Chem; 2019 Nov; 181():111572. PubMed ID: 31404859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease.
    Pathak C; Kabra UD
    Bioorg Chem; 2024 Mar; 144():107152. PubMed ID: 38290187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease.
    Ismaili L; Refouvelet B; Benchekroun M; Brogi S; Brindisi M; Gemma S; Campiani G; Filipic S; Agbaba D; Esteban G; Unzeta M; Nikolic K; Butini S; Marco-Contelles J
    Prog Neurobiol; 2017 Apr; 151():4-34. PubMed ID: 26797191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease.
    Wu WY; Dai YC; Li NG; Dong ZX; Gu T; Shi ZH; Xue X; Tang YP; Duan JA
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):572-587. PubMed ID: 28133981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core.
    Lin H; Li Q; Gu K; Zhu J; Jiang X; Chen Y; Sun H
    Curr Top Med Chem; 2017; 17(27):3000-3016. PubMed ID: 28714419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donepezil: an important prototype to the design of new drug candidates for Alzheimer's disease.
    Rodrigues Simões MC; Dias Viegas FP; Moreira MS; de Freitas Silva M; Riquiel MM; da Rosa PM; Castelli MR; dos Santos MH; Soares MG; Viegas C
    Mini Rev Med Chem; 2014 Jan; 14(1):2-19. PubMed ID: 24251806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitors.
    Bolea I; Gella A; Unzeta M
    J Neural Transm (Vienna); 2013 Jun; 120(6):893-902. PubMed ID: 23238976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyanobiphenyls: Novel H
    Godyń J; Zaręba P; Łażewska D; Stary D; Reiner-Link D; Frank A; Latacz G; Mogilski S; Kaleta M; Doroz-Płonka A; Lubelska A; Honkisz-Orzechowska E; Olejarz-Maciej A; Handzlik J; Stark H; Kieć-Kononowicz K; Malawska B; Bajda M
    Bioorg Chem; 2021 Sep; 114():105129. PubMed ID: 34217977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer's Disease Therapy.
    Zagórska A; Jaromin A
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32717806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
    Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
    Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multitarget Tacrine Hybrids with Neuroprotective Properties to Confront Alzheimer's Disease.
    Spilovska K; Korabecny J; Nepovimova E; Dolezal R; Mezeiova E; Soukup O; Kuca K
    Curr Top Med Chem; 2017; 17(9):1006-1026. PubMed ID: 27697055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease.
    Guzior N; Wieckowska A; Panek D; Malawska B
    Curr Med Chem; 2015; 22(3):373-404. PubMed ID: 25386820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrine-Natural-Product Hybrids for Alzheimer's Disease Therapy.
    Oset-Gasque MJ; Marco-Contelles JL
    Curr Med Chem; 2020; 27(26):4392-4400. PubMed ID: 29611473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
    Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C
    Health Technol Assess; 2012; 16(21):1-470. PubMed ID: 22541366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease.
    Batool A; Kamal MA; Rizvi SMD; Rashid S
    Curr Drug Metab; 2018; 19(8):704-713. PubMed ID: 29512457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease.
    Jeřábek J; Uliassi E; Guidotti L; Korábečný J; Soukup O; Sepsova V; Hrabinova M; Kuča K; Bartolini M; Peña-Altamira LE; Petralla S; Monti B; Roberti M; Bolognesi ML
    Eur J Med Chem; 2017 Feb; 127():250-262. PubMed ID: 28064079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifactorial Hypothesis and Multi-Targets for Alzheimer's Disease.
    Gong CX; Liu F; Iqbal K
    J Alzheimers Dis; 2018; 64(s1):S107-S117. PubMed ID: 29562523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning.
    Kabir MT; Uddin MS; Begum MM; Thangapandiyan S; Rahman MS; Aleya L; Mathew B; Ahmed M; Barreto GE; Ashraf GM
    Curr Pharm Des; 2019; 25(33):3519-3535. PubMed ID: 31593530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.